Reltecimod sodiumProduct ingredient for Reltecimod

Show full entry for Reltecimod
Name
Reltecimod sodium
Drug Entry
Reltecimod

Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).

See full entry for Reltecimod
Accession Number
DBSALT003172
Structure
MOLSDFPDBSMILESInChI
Synonyms
Not Available
External IDs
AB103 sodium